Shockwave Medical Inc (SWAV) FinancialsSWAVShockwave Medical Inc

Shockwave Medical Inc (SWAV) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Coronary, accounting for 75.2% of total sales, equivalent to $164.53M. Other significant revenue streams include Peripheral and Reducer. Understanding this composition is critical for investors evaluating how SWAV navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Shockwave Medical Inc maintains a gross margin of 87.11%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.38%, while the net margin is 25.29%. These profitability ratios, combined with a Return on Equity (ROE) of 24.73%, provide a clear picture of how effectively SWAV converts its operational activities into shareholder value.